Skip to main content
MatsukiyoCocokara & Co logo

MatsukiyoCocokara & Co — Investor Relations & Filings

Ticker · 3088 ISIN · JP3869010003 T Wholesale and retail trade
Filings indexed 67 across all filing types
Latest filing 2024-06-21 Annual Report
Country JP Japan
Listing T 3088

About MatsukiyoCocokara & Co

https://www.matsukiyococokara.com/en/

MatsukiyoCocokara & Co. is a holding company that operates an extensive network of retail drugstores and insurance dispensing pharmacies. The company's business activities include retail, wholesale, and management support. Its stores offer a wide range of products, including medicines, cosmetics, health foods, and beauty care items. The company manages its operations through its main segments, which include the Matsumotokiyoshi Group. In addition to its large physical retail footprint, the company maintains a growing online presence to serve its customers.

Recent filings

Filing Released Lang Actions
有価証券報告書-第17期(2023/04/01-2024/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header '有価証券報告書' (Securities Report), specifies the fiscal year (第17期, 2023-04-01 to 2024-03-31), and includes extensive XBRL-style metadata tags typical of a comprehensive annual financial filing. It is not an announcement, but the full report itself. FY 2024
2024-06-21 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is extremely short (628 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning '有価証券報告書' (Annual Securities Report, equivalent to 10-K in structure but filed under Japanese law) and confirming its accuracy ('記載内容が金融商品取引法令に基づき適正に記載されていることを確認いたしました'). The document itself is a '確認書' (Confirmation document) submitted to the Kanto Local Finance Bureau Director, signed by the CEO and CFO, confirming the appropriateness of the Annual Securities Report for the fiscal year ending March 31, 2024. Since this is a confirmation document related to the Annual Securities Report (10-K equivalent) and not the full report itself, and given its brevity and nature as a formal confirmation/attestation, it most closely aligns with a general regulatory filing or a specific confirmation related to the annual filing. However, since the core subject is the confirmation of the Annual Securities Report, and there is no specific code for a 'Confirmation of 10-K', we must evaluate the closest fit. It is not an Earnings Release (ER), Interim Report (IR), or Audit Report (AR). It is a formal regulatory submission confirming the accuracy of the main annual filing. Given the options, and recognizing this is a formal regulatory attestation, 'RNS' (Regulatory Filings - general fallback) is plausible, but '10-K' is the underlying document being attested to. Since the document is a confirmation *about* the annual report, and not the report itself, and it's a formal submission, it fits best as a specific regulatory filing related to the annual cycle. In many contexts, such confirmations are filed alongside or shortly after the main 10-K. Given the options, and the focus on the annual report confirmation, if a specific confirmation code isn't available, 'RNS' is the safest fallback for a non-standard, short regulatory document. However, if we interpret this as the formal certification required for the annual filing, it is intrinsically linked to the 10-K process. Since it is a formal, required confirmation document, and not a general announcement, I will classify it as 'RNS' as it is a specific regulatory confirmation document that doesn't fit the other detailed categories. FY 2024
2024-06-21 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is extremely short (630 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted to the '関東財務局長' (Kanto Local Finance Bureau Director) based on Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act. The core content confirms that the President and CFO have verified the appropriateness of the '第17期第3四半期' (17th Fiscal Period, 3rd Quarter) '四半期報告書' (Quarterly Report) for the period ending December 31, 2023. Since this document is a confirmation *about* the Quarterly Report, and not the comprehensive Quarterly Report itself, it fits best under the category for general regulatory announcements or filings that don't match a specific report type. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for this specific confirmation document, although it relates to an Interim/Quarterly Report (IR). However, since it is a confirmation document and not the full IR, RNS is safer than IR.
2024-02-14 Japanese
四半期報告書-第17期第3四半期(2023/10/01-2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis, and business status for the third quarter (Q3) of the fiscal year ending 2024. It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is extremely short (627 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted to the '関東財務局長' (Kanto Local Finance Bureau Director) based on Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act. The core content confirms the appropriateness of the '四半期報告書' (Quarterly Report) for the second quarter (July 1 to September 30, 2023). Since this document is a confirmation *about* the Quarterly Report, and not the comprehensive Quarterly Report itself, it fits best under the general 'Regulatory Filings' category (RNS) or potentially an 'Audit Report/Information' (AR) if it were a formal certification, but given the context of confirming the filing's appropriateness, RNS is the most appropriate fallback for a specific confirmation document that isn't a primary financial statement or a standard earnings release.
2023-11-14 Japanese
四半期報告書-第17期第2四半期(2023/07/01-2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and shareholding information for the second quarter of the 17th fiscal period (ending September 30, 2023). As it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q2 2024
2023-11-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.